Na+/H+ Exchanger 1 Inhibition Overcomes Venetoclax Resistance in Acute Myeloid Leukemia
Cells · 2025
DOI: 10.3390/cells14221759 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Shin Young Hyun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea. Hauptthemen laut MEDLINE: Bridged Bicyclo Compounds, Heterocyclic, Sulfonamides, Drug Resistance, Neoplasm, Sodium-Hydrogen Exchanger 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT and Future Planning, Yonsei University College of Medicine.
Abstract (Originalsprache)
Despite advances with novel targeted agents (e.g., BCL-2 or IDH inhibitors) combined with chemotherapy for acute myeloid leukemia (AML), drug resistance persists. We investigated whether blocking Na+/H+ exchanger 1 (NHE1) could enhance AML cell sensitivity to the BCL-2 inhibitor venetoclax and sought to determine the molecular mechanisms. Our results demonstrated that co-treatment with venetoclax and the NHE1 inhibitor 5-(N,N-hexamethylene) amiloride (HMA) synergistically induced apoptosis in both venetoclax-sensitive and -resistant leukemic cell lines. Specifically, the combination significantly increased apoptosis in venetoclax-resistant THP-1 cells to 72.28% (17.79% with 100 nM venetoclax and 10.15% with 10 μM HMA alone; p < 0.001). Conversely, another venetoclax-resistant line, U-937, showed no significant apoptotic response to the combination. In THP-1 cells, this synergy was mediated via a caspase-dependent programmed cell death pathway, evidenced by an increased BAX/BCL-2 ratio, mitochondrial cytochrome c release, and subsequent caspase-9 and caspase-3 activation. Furthermore, co-treatment downregulated the anti-apoptotic protein MCL-1 and reduced PI3K and Akt phosphorylation, suggesting that inhibition of these survival pathways also contributed to the synergistic effect. Inhibition of NHE1 may substantially enhance venetoclax sensitivity in certain AML models, particularly in venetoclax-resistant THP-1 cells but not in U-937, highlighting biological diversity and the probable involvement of alternative survival pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- Blood Cancer Research Institute, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.
ORCID-Profile: Shin Young Hyun, Eun Jung Na, Yu Ri Kim, June-Won Cheong
Förderung
- Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT and Future Planning
- Yonsei University College of Medicine
Zitieren
APA
Hyun, S. Y., Na, E. J., Kim, Y. R., Min, Y. H., & Cheong, J. W. (2025). Na+/H+ Exchanger 1 Inhibition Overcomes Venetoclax Resistance in Acute Myeloid Leukemia. Cells. https://doi.org/10.3390/cells14221759
Vancouver
Hyun SY, Na EJ, Kim YR, Min YH, Cheong JW. Na+/H+ Exchanger 1 Inhibition Overcomes Venetoclax Resistance in Acute Myeloid Leukemia. Cells. 2025. doi:10.3390/cells14221759
BibTeX
@article{Hyun2025,
author = {Hyun, Shin Young and Na, Eun Jung and Kim, Yu Ri and Min, Yoo Hong and Cheong, June-Won},
title = {Na+/H+ Exchanger 1 Inhibition Overcomes Venetoclax Resistance in Acute Myeloid Leukemia},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14221759}
}
EUVIMED